VRTX
|Vertex Pharmaceuticals Inc
NASDAQ
Current Price
USD 435.32
Change
USD -11.86 (-2.65%)
P/E Ratio
Dividend Yield
Market Cap
112.64B
Volume
1.36M
Open
USD 444.37
Previous Close
USD 447.18
52-Week High
USD 519.88
52-Week Low
USD 377.85
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 ...
| Declared Date | Record Date | Payment Date | Amount | Frequency |
|---|
Gilead Sciences, Inc.
GILD • NASDAQ
Abbvie Inc
ABBV • NEW YORK STOCK EXCHANGE INC.
Merck & Co Inc
MRK • NEW YORK STOCK EXCHANGE INC.
Bristol-Myers Squibb Co.
BMY • NEW YORK STOCK EXCHANGE INC.
Johnson & Johnson
JNJ • NEW YORK STOCK EXCHANGE INC.
Enzon Pharmaceuticals Inc
ENZN • OTC MARKETS